Updates from The Motley Fool

Latest updates on Antares Pharma, Inc. from Fool.com.


Stock Performance

ATRS vs. S&P 500 | 2 Year Performance
ATRS 1-Day Stock Chart
ATRS 5-Day Stock Chart
ATRS 1-Month Stock Chart
ATRS 3-Month Stock Chart
ATRS 6-Month Stock Chart
ATRS 1-Year Stock Chart
ATRS 2-Year Stock Chart
ATRS 5-Year Stock Chart
View Interactive ATRS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Antares Pharma, Inc..
Current Price: $0.92
Prev Close: $0.97
Open: $0.96
Bid: $0.89
Ask: $1.12
Day's Range: $0.91 - $0.98
52wk Range: $0.67 - $2.60
Volume: 513,662
Avg Vol 902,681
Market Cap: $142.44M
P/E (ttm): -6.93
EPS (ttm): -$0.14
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Antares Pharma, Inc..
CAPS Rating 2 out of 5
 
181 Outperform
15 Underperform
CAPS All Stars
 
10 Outperform
5 Underperform

How do you think Antares Pharma, Inc. will perform against the market?



You pick for Antares Pharma, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paul K. Wotton, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Antares Pharma, Inc..

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT